Kilitch Drugs (India) Ltd. (KILITCH)
Market Closed
16 Oct, 10:00 PM
MSE XNSE Primary MSE ₹
230. 00
-7.2
-3.0354%
₹
- Market Cap
37.69 P/E Ratio
- Div Yield
4,015 Volume
7.3 Eps
₹ 237.2
Previous Close Want to track KILITCH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | 2.54 |
| | | - | 4.97 |
| | | - | - |
| | | - | 3.71 |
| | | - | 5.36 |
| | | - | - |
| | | - | - |
| | | - | 1.81 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 1.01 |
| | | - | 0.38 |
| | | - | - |
| | | - | 0.61 |
| | | - | 0.34 |
| | | - | 1.31 |
| | | - | - |
| | | - | 0.09 |
KILITCH Earnings Reports FAQ
What is the earnings per share (EPS) for KILITCH?
The current EPS is 7.3.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately 32.17%, reflecting the KILITCH's performance and MSE market conditions.
When is the next earnings release date?
Kilitch Drugs (India) Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kilitch Drugs (India) Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KILITCH at this time, as Kilitch Drugs (India) Ltd has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
